ACADIA Pharmaceuticals Inc (ACAD) earnings · P/E 8.8, rev $1.07B
These earnings events as JSON? API free 100/dayACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
This ACAD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ACAD revenue for 2025-12-31 was $1.07B. Net income was $391.0M. Revenue was up 11.9% from 2024-12-31 to 2025-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 8.8.
When the next ACAD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 11.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ACAD research stays on the stock page; the tape stays on the quote page.
ACAD earnings FAQ
What are ACAD's latest revenue and net income?
Latest cached ACADIA Pharmaceuticals Inc (ACAD) revenue for Dec 31, 2025 was $1.07B. Net income was $391.0M. Statements: https://lician.com/financials/acad
What is ACAD's latest diluted EPS?
Latest cached ACADIA Pharmaceuticals Inc (ACAD) diluted EPS for Dec 31, 2025 was $2.30.
What period does the latest ACAD earnings print cover?
The latest cached ACADIA Pharmaceuticals Inc (ACAD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ACAD revenue change from the prior cached period?
Cached ACADIA Pharmaceuticals Inc (ACAD) revenue was up 11.9% from $957.8M (Dec 31, 2024) to $1.07B (Dec 31, 2025). Statements: https://lician.com/financials/acad
What is ACAD's P/E ratio?
ACADIA Pharmaceuticals Inc (ACAD) trailing P/E is 8.85 on the latest cached fundamentals snapshot.
Where are ACAD earnings listed?
Cached earnings facts for ACADIA Pharmaceuticals Inc (ACAD) are listed at https://lician.com/earnings/acad. Statements: https://lician.com/financials/acad
Not investment advice.